David A. Sinclair A.O., Ph.D.
About David A. Sinclair A.O., Ph.D.
David A. Sinclair A.O., Ph.D., is a co-founder and professor at Harvard Medical School, known for his pioneering research on aging and age-associated diseases.
Company
David A. Sinclair is currently associated with multiple companies including Fully Aligned Co, LLC, Lifespan Communications, Immetas Therapeutics, Animal Bioscience, Life Biosciences, Cantata Bio, Metrobiotech International, EdenRoc Sciences, and InsideTracker. He has held positions of Co-Founder, Board Member, Scientific Advisor, and Investor across these organizations. Sinclair has co-founded several companies aimed at advancing research in biotechnology and genomics, tackling issues related to aging, neurological diseases, and metabolic disorders.
Title
David A. Sinclair holds various titles across industries primarily focused on biotechnology and communications. These titles include Co-Founder, Broadcaster, Board Member, Scientific Advisor, and Investor. His extensive involvement across multiple organizations highlights his dedication to advancing scientific research and communication.
Education and Expertise
David A. Sinclair studied at the University of New South Wales (UNSW) where he achieved a B.S. & Ph.D. in Genetics, Molecular Biology, Biochemistry, and Marine Biology from 1987 to 1995. He then pursued Postdoctoral Training at the Massachusetts Institute of Technology (MIT) from 1995 to 1999, where he worked under Dr. Leonard Guarente. His research expertise spans across fields such as chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration, and cancer.
Background
David A. Sinclair was recruited to Harvard Medical School in 1999, where he is now a tenured professor in the Department of Genetics. His research focuses on the role of sirtuins in disease and aging, with significant contributions to understanding the causes of aging in yeast and the implications of Sir2 in epigenetic changes driven by genome instability. Sinclair is also the co-founder of several biotechnology companies addressing aging and related diseases.
Achievements
David A. Sinclair has authored over 170 papers, holds more than 50 patents, and co-founded the journal 'Aging'. He launched the Lifespan Podcast in 2022 and his book 'Lifespan: Why We Age and Why We Don't Have To' is a New York Times bestseller. He has been honored with more than 40 awards, including the Excellence in Teaching Award from Harvard and the TIME100's most influential people. Sinclair's work is widely recognized with an h-index of 113 and over 85,000 citations.